Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 7,803,000 | 6,960,000 | 7,925,000 | 7,769,000 | 7,082,000 |
| Cost of Goods | 1,579,000 | 1,445,000 | 1,624,000 | 1,569,000 | 1,501,000 |
| Gross Profit | 6,224,000 | 5,515,000 | 6,301,000 | 6,200,000 | 5,581,000 |
| Operating Expenses | 16,618,000 | 2,930,000 | 4,317,000 | 2,873,000 | 3,107,000 |
| Operating Income | -10,394,000 | 2,586,000 | 1,984,000 | 3,327,000 | 2,474,000 |
| Interest Expense | 247,000 | 240,000 | 254,000 | 256,000 | 254,000 |
| Other Income | 387,000 | 234,000 | 347,000 | 570,000 | 209,000 |
| Pre-tax Income | -10,254,000 | 2,580,000 | 2,077,000 | 3,641,000 | 2,429,000 |
| Income Tax | 242,000 | 559,000 | -105,000 | 589,000 | 468,000 |
| Net Income Continuous | -10,496,000 | 2,021,000 | 2,182,000 | 3,052,000 | 1,961,000 |
| Net Income | $-10,496,000 | $2,021,000 | $2,183,000 | $3,052,000 | $1,960,000 |
| EPS Basic Total Ops | -8.45 | 1.63 | 1.75 | 2.46 | 1.57 |
| EPS Basic Continuous Ops | -8.44 | 1.63 | 1.76 | 2.46 | 1.58 |
| EPS Diluted Total Ops | -8.45 | 1.61 | 1.75 | 2.43 | 1.56 |
| EPS Diluted Continuous Ops | -8.44 | 1.61 | 1.74 | 2.43 | 1.56 |
| EPS Diluted Before Non-Recurring Items | N/A | 2.03 | 1.86 | 2.47 | 2.01 |
| EBITDA(a) | $-9,696,000 | $3,274,000 | $2,671,000 | $4,013,000 | $3,165,000 |